PTGDR2 and COVID-19: A deep analysis on the subsets demonstrated that the absolute number of ILC1 (CD117-CXCR3+) and ILCp (CD117-CRTH2-) decreased in COVID-19 patients as well as ILC2 only in severe patients compared to moderate [55].